SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-16-000186
Filing Date
2016-10-03
Accepted
2016-10-03 06:05:01
Documents
4
Period of Report
2016-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k10316.htm 8-K 37151
2 EXHIBIT 10.1 exhibit10110316.htm EX-10.1 282002
3 EXHIBIT 99.1 exhibit99110316.htm EX-99.1 14816
4 a991image1.gif GRAPHIC 1570
  Complete submission text file 0000891293-16-000186.txt   337684
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 161914360
SIC: 2834 Pharmaceutical Preparations